
Zhao Jiayi
BIOGRAPHY
Zhao Jiayi (born February 6, 2003) is a Chinese actor. He is best known for playing Lin Xianyue in the historical boys’ love drama Journey With You (2026).
BLGLFlix editorial view
He was born in February 2003, which means the Chinese television industry he entered is not the one that existed when he was a child.
Zhao Jiayi plays Lin Xianyue in Journey With You, the 2026 historical romance produced by The One Studio and released through GagaOOLala. Chinese adaptations of boys love novels were among the most watched dramas on domestic platforms at the start of the 2020s. By the time someone born in 2003 was old enough to audition, that route had closed and the work had moved to co-productions and outward facing distribution.
An eight episode costume drama shot in China and streamed by a Taiwan based service is what that looks like in practice. The production standards are the ones Chinese period television built up over a decade. The publicity apparatus around it is almost nothing, because the usual promotional channels are not available for this kind of material.
His birth date is one of the few personal details on this page that could be confirmed and written. The rest of the biographical block stays empty: no agency, no training record, no debut year, no verified public account. That is not an oversight in this case so much as a description of the sector. Actors working in Chinese boys love productions are the least documented group in this catalogue by a clear margin.
His role is in the supporting ensemble around the two leads, Tang Bide and Wang Jinghan, in a story built on a court conspiracy. What can be said about the performance belongs on the series page. What belongs here is the shape of the record, and its shape is deliberate.
PROFILE DETAILS
- Real Name
- Zhao Jiayi
- Born
- (Age 23)
- Western Zodiac
- Aquarius ♒
- Chinese Zodiac
- Goat 🐐
- Profession
- Nationality



Discussion 0 comments
Join other fans talking about Zhao Jiayi. Be kind, no spoilers without tags, no spam.
No comments yet.
Share the first reaction below.